39605963|t|Dexmedetomidine Attenuated Neuron Death, Cognitive Decline, and Anxiety-Like Behavior by Inhibiting CXCL2 in CA1 Region of AD Mice.
39605963|a|Purpose: beta-amyloid overload-induced neuroinflammation and neuronal loss are key pathological changes that occur during the progression of Alzheimer's disease (AD). Dexmedetomidine (Dex) exhibits neuroprotective and anti-inflammatory effects on the nervous system. However, the effect of Dex in AD mice remains unclear, and its neuroprotective regulatory mechanism requires further investigation. This study aimed to reveal how Dex protects against Abeta induced neuropathological changes and behavior dysfunction in AD mice. Methods: An AD mouse model was established by the injection of Abeta into the brains of mice, followed by intraperitoneal injection with Dex. CXCL2 overexpression and Yohimbine, a Dex inhibitor, were used to investigate the role of Dex and CXCL2 in the regulation of neuronal loss, cognitive decline, and anxiety-like behavior in AD mice. Behavioral tests were performed to evaluate the cognitive and anxiety status of the mice. Nissl staining and immunofluorescence experiments were conducted to evaluate the status of the hippocampal neurons and astrocytes. qRT-PCR was performed to detect the expression of CXCL2, IL-1beta, INOS, SPHK1, Bcl2, IFN-gamma, and Caspase 1. The malondialdehyde (MDA) level was detected using an ELISA kit. Terminal TUNEL and Fluoro-Jade C (FJC) staining were used to measure the cell apoptosis rate. Results: In AD mice, cognitive decline and anxiety-like behaviors were significantly improved by the Dex treatment. The number of neurons was increased in mice in the Dex + AD group compared to those in the AD group, and the number of astrocytes was not significantly different between the two groups. CXCL2, IL-1beta, iNOS, and SPHK1 levels were significantly lower in Dex-treated AD mice than those in AD mice. Overloading of CXCL2 or Yohimbine reversed the protective effect of Dex on neuron number and cognitive and anxiety symptoms in AD mice. Conclusion: Our results suggest that Dex exerts neuroprotective effects by downregulating CXCL2. Dex shows potential as a therapeutic drug for AD.
39605963	0	15	Dexmedetomidine	Chemical	MESH:D020927
39605963	27	39	Neuron Death	Disease	MESH:D009410
39605963	41	58	Cognitive Decline	Disease	MESH:D003072
39605963	64	71	Anxiety	Disease	MESH:D001007
39605963	100	105	CXCL2	Gene	20310
39605963	123	125	AD	Disease	MESH:D000544
39605963	126	130	Mice	Species	10090
39605963	171	188	neuroinflammation	Disease	MESH:D000090862
39605963	193	206	neuronal loss	Disease	MESH:D009410
39605963	273	292	Alzheimer's disease	Disease	MESH:D000544
39605963	294	296	AD	Disease	MESH:D000544
39605963	299	314	Dexmedetomidine	Chemical	MESH:D020927
39605963	316	319	Dex	Chemical	MESH:D020927
39605963	355	367	inflammatory	Disease	MESH:D007249
39605963	422	425	Dex	Chemical	MESH:D020927
39605963	429	431	AD	Disease	MESH:D000544
39605963	432	436	mice	Species	10090
39605963	562	565	Dex	Chemical	MESH:D020927
39605963	583	588	Abeta	Gene	11820
39605963	597	614	neuropathological	Disease	MESH:D009422
39605963	627	647	behavior dysfunction	Disease	MESH:D001523
39605963	651	653	AD	Disease	MESH:D000544
39605963	654	658	mice	Species	10090
39605963	672	674	AD	Disease	MESH:D000544
39605963	675	680	mouse	Species	10090
39605963	723	728	Abeta	Gene	11820
39605963	748	752	mice	Species	10090
39605963	797	800	Dex	Chemical	MESH:D020927
39605963	802	807	CXCL2	Gene	20310
39605963	827	836	Yohimbine	Chemical	MESH:D015016
39605963	840	843	Dex	Chemical	MESH:D020927
39605963	892	895	Dex	Chemical	MESH:D020927
39605963	900	905	CXCL2	Gene	20310
39605963	927	940	neuronal loss	Disease	MESH:D009410
39605963	942	959	cognitive decline	Disease	MESH:D003072
39605963	965	972	anxiety	Disease	MESH:D001007
39605963	990	992	AD	Disease	MESH:D000544
39605963	993	997	mice	Species	10090
39605963	1061	1068	anxiety	Disease	MESH:D001007
39605963	1083	1087	mice	Species	10090
39605963	1270	1275	CXCL2	Gene	20310
39605963	1277	1285	IL-1beta	Gene	16176
39605963	1287	1291	INOS	Gene	18126
39605963	1293	1298	SPHK1	Gene	20698
39605963	1300	1304	Bcl2	Gene	12043
39605963	1306	1315	IFN-gamma	Gene	15978
39605963	1321	1330	Caspase 1	Gene	12362
39605963	1336	1351	malondialdehyde	Chemical	MESH:D008315
39605963	1353	1356	MDA	Chemical	MESH:D008315
39605963	1416	1429	Fluoro-Jade C	Chemical	MESH:C534582
39605963	1431	1434	FJC	Chemical	MESH:C534582
39605963	1503	1505	AD	Disease	MESH:D000544
39605963	1506	1510	mice	Species	10090
39605963	1512	1529	cognitive decline	Disease	MESH:D003072
39605963	1534	1541	anxiety	Disease	MESH:D001007
39605963	1592	1595	Dex	Chemical	MESH:D020927
39605963	1646	1650	mice	Species	10090
39605963	1658	1661	Dex	Chemical	MESH:D020927
39605963	1664	1666	AD	Disease	MESH:D000544
39605963	1698	1700	AD	Disease	MESH:D000544
39605963	1793	1798	CXCL2	Gene	20310
39605963	1800	1808	IL-1beta	Gene	16176
39605963	1810	1814	iNOS	Gene	18126
39605963	1820	1825	SPHK1	Gene	20698
39605963	1861	1864	Dex	Chemical	MESH:D020927
39605963	1873	1875	AD	Disease	MESH:D000544
39605963	1876	1880	mice	Species	10090
39605963	1895	1897	AD	Disease	MESH:D000544
39605963	1898	1902	mice	Species	10090
39605963	1919	1924	CXCL2	Gene	20310
39605963	1928	1937	Yohimbine	Chemical	MESH:D015016
39605963	1972	1975	Dex	Chemical	MESH:D020927
39605963	1997	2027	cognitive and anxiety symptoms	Disease	MESH:D001008
39605963	2031	2033	AD	Disease	MESH:D000544
39605963	2034	2038	mice	Species	10090
39605963	2077	2080	Dex	Chemical	MESH:D020927
39605963	2130	2135	CXCL2	Gene	20310
39605963	2137	2140	Dex	Chemical	MESH:D020927
39605963	2183	2185	AD	Disease	MESH:D000544
39605963	Negative_Correlation	MESH:D020927	MESH:D009410
39605963	Association	MESH:D001008	20310
39605963	Association	MESH:D003072	20310
39605963	Negative_Correlation	MESH:D020927	20310
39605963	Negative_Correlation	MESH:D020927	MESH:D000544
39605963	Association	MESH:D001007	20310
39605963	Negative_Correlation	MESH:D020927	20698
39605963	Negative_Correlation	MESH:D020927	MESH:D001008
39605963	Negative_Correlation	MESH:D020927	11820
39605963	Negative_Correlation	MESH:D020927	16176
39605963	Negative_Correlation	MESH:D015016	MESH:D001008
39605963	Association	MESH:D001523	11820
39605963	Association	MESH:D009410	20310
39605963	Positive_Correlation	MESH:D009422	11820
39605963	Association	MESH:D000544	20310
39605963	Negative_Correlation	MESH:D020927	18126
39605963	Association	MESH:D020927	MESH:D001523
39605963	Negative_Correlation	MESH:D020927	MESH:D007249
39605963	Negative_Correlation	MESH:D020927	MESH:D009422
39605963	Negative_Correlation	MESH:D020927	MESH:D003072
39605963	Negative_Correlation	MESH:D015016	MESH:D020927
39605963	Negative_Correlation	MESH:D020927	MESH:D001007

